Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2258697/will-masimo-masi-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2258697
Apr 19, 2024 - Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Masimo's (MASI) ORi Favored by Study for PaO2 Information
https://www.zacks.com/stock/news/2196904/masimo-s-masi-ori-favored-by-study-for-pao2-information?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196904
Dec 12, 2023 - Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.
0
Here's Why You Should Retain Masimo (MASI) Stock for Now
https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710
Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
What's in Store for Edwards Lifesciences (EW) in Q4 Earnings?
https://www.zacks.com/stock/news/2212913/what-s-in-store-for-edwards-lifesciences-ew-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212913
Jan 19, 2024 - Edwards Lifesciences' (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery portfolio in Critical Care.
0
Here's Why You Should Add Masimo (MASI) to Your Portfolio Now
https://www.zacks.com/stock/news/2227728/here-s-why-you-should-add-masimo-masi-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227728
Feb 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
Are Medical Stocks Lagging Masimo (MASI) This Year?
https://www.zacks.com/stock/news/2230943/are-medical-stocks-lagging-masimo-masi-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2230943
Feb 23, 2024 - Here is how Masimo (MASI) and CochLear Ltd. Unsponsored ADR (CHEOY) have performed compared to their sector so far this year.
0
Masimo (MASI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2232801/masimo-masi-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2232801
Feb 27, 2024 - The headline numbers for Masimo (MASI) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2250299/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2250299
Apr 04, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
Pages: 12
<Page 2